original ) (raw )Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer
Maarten Brom
EJNMMI research, 2012
View PDFchevron_right
Relative reactivity of DTPA, immunoreactive antibody-DTPA conjugates, and nonimmunoreactive antibody-DTPA conjugates toward indium-111
Mercedes Ebbert
1985
View PDFchevron_right
Radiolabelling of monoclonal antibodies: Optimization of conjugation of DTPA to F(ab?) 2-fragments and a novel measurement of the degree of conjugation using Eu(III)-labelling
Pirkko Vihko
European Journal of Nuclear Medicine, 1989
View PDFchevron_right
Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies
David Colcher , Saed Mirzadeh
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
View PDFchevron_right
The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method
a najafi
Journal of Immunological Methods, 1983
View PDFchevron_right
Synthesis and evaluation of a monoreactive DOTA derivative for indium-111-based residualizing label to estimate protein pharmacokinetics
Kazuma Ogawa
Journal of Pharmacy and Pharmacology, 2002
View PDFchevron_right
Practical Aspects of labeling DTPA-and DOTA-Peptides with 90 Y , 111 In , 177 Lu , and 68 Ga for Peptide-Receptor Scintigraphy and Peptide-Receptor Radionuclide Therapy in Preclinical and Clinical Applications
Neil Petry
2012
View PDFchevron_right
Labeling of monoclonal antibodies with radionuclides
Seetharama Acharya
Seminars in Nuclear Medicine, 1989
View PDFchevron_right
Facile synthesis and evaluation of C-functionalized benzyl-1-oxa-4,7,10-triazacyclododecane-N,N′,N″-triacetic acid as chelating agent for 111In-labeled polypeptides
Yasushi Arano
Bioorganic & Medicinal Chemistry, 2012
View PDFchevron_right
Modification of antibody isoelectric point affects biodistribution of 111-indium-labeled antibody
Anthony Petrick
Nuclear Medicine and Biology, 1996
View PDFchevron_right
Progress in research on ligands, nuclides and techniques for labeling monoclonal antibodies
Ronnie Mease
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
View PDFchevron_right
Streptavidin in Antibody Pretargeting. 5. Chemical Modification of Recombinant Streptavidin for Labeling with the α-Particle-Emitting Radionuclides 213 Bi and 211 At
D Scott Wilbur
Bioconjugate Chemistry, 2008
View PDFchevron_right
Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab′)2 fragments of anti-carcinoembryonic antigen antibody—I. A new reproducible synthetic method
Ronnie Mease
Nuclear Medicine and Biology, 1993
View PDFchevron_right
Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid for radiolabeling proteins
Markus Beitzel
Nuclear Medicine and Biology, 2003
View PDFchevron_right
Significance of 111In-DTPA chelate in renal radioactivity levels of 111In-DTPA-conjugated peptides
Kazuma Ogawa
Nuclear Medicine and Biology, 2001
View PDFchevron_right
Radiolabeling of DOTA-like conjugated peptides with generator-produced 68Ga and using NaCl-based cationic elution method
Andreas Odparlik
View PDFchevron_right
An optimized antibody-chelator conjugate for imaging of carcinoembryonic antigen with indium-111
Patrick Rogers
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1990
View PDFchevron_right
Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent
D Scott Wilbur
Proceedings of the National Academy of Sciences, 1988
View PDFchevron_right
In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand
David Colcher
European Journal of Nuclear Medicine and Molecular Imaging, 1998
View PDFchevron_right
Aminooxy���functionalized DOTA for radiolabeling of oxidized antibodies: evaluation of site���specific 111In���labeled trastuzumab
Parasuraman Padmanabhan
2012
View PDFchevron_right
Labeling of somatostatin with 99mTc using DTPA and D-Pa As bifunctional agents
Perihan Unak
2006
View PDFchevron_right
Evaluation of a new DTPA-derivative chelator: Comparative biodistribution and imaging studies of 111In-labeled B3 monoclonal antibody in athymic mice bearing human epidermoid carcinoma xenografts
L. Camera
Nuclear Medicine and Biology, 1993
View PDFchevron_right
Evaluation of a Maleimido Derivative of CHX-A′′ DTPA for Site-Specific Labeling of Affibody Molecules
Niklaus Marti , Magnus Hjertman , Vladimir Tolmachev
Bioconjugate Chemistry, 2008
View PDFchevron_right
Experimental Pretargeting Studies of Cancer with a Humanized anti-CEA × Murine anti-[In-DTPA] Bispecific Antibody Construct and a 99m Tc-/ 188 Re-Labeled Peptide
Jacques Barbet
Bioconjugate Chemistry, 2000
View PDFchevron_right
Direct Procedure for the Production of 211At-Labeled Antibodies with an -Lysyl-3-(Trimethylstannyl)Benzamide Immunoconjugate
Sofia H L Frost , Tom Bäck
Journal of Nuclear Medicine, 2008
View PDFchevron_right
Chelating polymer modified monoclonal antibodies for radioimmunodiagnostics and radioimmunotherapy
Ban-an Khaw
Journal of Controlled Release, 1993
View PDFchevron_right
Efficient conjugation of DTPA to an IgM monoclonal antibody in ascites fluid
Roger M Macklis
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1988
View PDFchevron_right
Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications
Mark Sherman
Protein Engineering Design and Selection, 2004
View PDFchevron_right
Enhanced Target-Specific Accumulation of Radiolabeled Antibodies by Conjugating Arginine-Rich Peptides as Anchoring Molecules
Yasushi Arano
Bioconjugate Chemistry, 2010
View PDFchevron_right
Conventional and High-Yield Synthesis of DTPA-Conjugated Peptides: Application of a Monoreactive DTPA to DTPA- d -Phe 1 -octreotide Synthesis †
Yasushi Arano
Bioconjugate Chemistry, 1997
View PDFchevron_right
A Versatile Bifunctional Chelate for Radiolabeling Humanized Anti-CEA Antibody with In-111 and Cu-64 at Either Thiol or Amino Groups: PET Imaging Of CEA-Positive Tumors with Whole Antibodies
Paul Yazaki
Bioconjugate Chemistry, 2008
View PDFchevron_right
Development of 111In-DTPA-human polyclonal antibody complex for long-term inflammation/infection detection
Saeed Rajabifar
Nukleonika, 2005
View PDFchevron_right
Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide
hermann oppermann
Proceedings of the National Academy of Sciences, 1995
View PDFchevron_right
The labeling of high affinity sites of antibodies with 99mTc
William Eckelman
International Journal of Nuclear Medicine and Biology, 1985
View PDFchevron_right